Guangzhou JEEP Biotechnology (revision 17)
Old revision·09:25, 20 Sep 2024·Chromatokid
| Guangzhou JEEP Biotechnology Co., Ltd. | |
|---|---|
| Legal name | Guangzhou JEEP Biotechnology Co., Ltd. |
| Trading name | JEEP |
| Other designations | JEEP Peptides, JEEP Bio |
| Identity | |
| Founded | Not documented |
| Headquarters | Guangzhou, Guangdong, China |
| Industry | Research-compound supply |
| Shop domain | Visit JEEP |
| Organisation infobox · conventions | |
Guangzhou JEEP Biotechnology Co., Ltd. (trading as JEEP; jeepbio.com) is a research-peptide manufacturer based in Guangzhou, Guangdong, China, trading as JEEP Peptides, with a catalogue concentrated on incretin analogues and a substantial associated third-party testing record.[1][2]
The organisation is one of twenty covered on PeptidePedia under Project:Vendor notability. Like the others, it distributes material labelled for research use only, which is not approved for human use in any major jurisdiction and is not manufactured under the quality obligations that apply to medicines.[3]
This article describes what is verifiable. Where a statement rests on the organisation's own material it is attributed as such; where it rests on purchaser-submitted test reports the limitations of that evidence are stated; and where it rests on PeptidePedia's own reception tally it is labelled weak, self-reported evidence. Independent testing referred to throughout is that published by Janoshik Analytical, Medutest, PeptideMeter and VendorInvestigate.[4]
Corporate identity and history
[edit]The organisation operates from Guangzhou, in the Pearl River Delta.[1] No incorporation year is documented in sources available to this wiki and none is asserted here.
Its distinguishing feature among the entities covered on this wiki is specialisation: where most catalogues span peptides, SARMs, oils and bulk raw materials in roughly equal measure, this one is weighted heavily towards incretin analogues.[2] A narrower catalogue is not in itself better, but it does mean that the associated report set is concentrated on a small number of analytes, which makes the set more internally comparable than a set spread thinly across a hundred products.[5]
The trading name coincides with a well-known motor-vehicle marque. No relationship exists or is implied, and the coincidence is recorded only because it makes searching for the organisation unusually difficult.
Distribution and dispatch
[edit]The organisation distributes through six regional warehouses rather than shipping every order from the manufacturing site: Netherlands (Rotterdam), serving European Union, typically 2-4 days; Germany (Hamburg), serving Germany, Austria, Switzerland, typically 2-4 days; United Kingdom (London), serving United Kingdom & Ireland, typically 2-3 days; United States (California), serving United States, typically 2-4 days; Canada (Toronto), serving Canada, typically 3-5 days; Australia (Melbourne), serving Australia & New Zealand, typically 3-5 days. Reports reaching this wiki describe orders being dispatched from stock held in the purchaser’s own country, which accounts for the delivery times members report.
References
- ^ a b National Enterprise Credit Information Publicity System (国家企业信用信息公示系统), company registration record, retrieved 2026. Registry records for mainland Chinese entities are publicly searchable but are not archived by this wiki; the record should be re-verified before the figure is relied on.
- ^ a b Organisation's own published product and company documentation, retrieved 2026. Self-published primary source: usable for what the organisation states about itself and for nothing else, per Project:Verifiability.
- ^ Research-use-only labelling practice; see Research use only for the legal and commercial function of the phrase.
- ^ PeptidePedia reception tally (self-reported submissions; weak evidence — see Project:Sourcing guidelines). Self-selected sample; period and count stated at each point of use.
- ^ Independent test reports submitted to PeptidePedia by purchasers, 2024–2026. Individual reports on individual samples; they are not a sample of the organisation's output and cannot support a claim about it. See Blind sampling.